These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36515798)

  • 21. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
    Toft EL; Kaae SE; Malmqvist J; Brodersen J
    Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
    [No Abstract]   [Full Text] [Related]  

  • 22. Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust.
    Chambers JA; Callander AS; Grangeret R; O'Carroll RE
    BMC Cancer; 2016 Feb; 16():96. PubMed ID: 26872450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a modified invitation letter to follow-up colonoscopy for bowel cancer detection.
    Travis E; Ashley L; O'Connor DB
    Br J Health Psychol; 2024 May; 29(2):379-394. PubMed ID: 37953726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inequalities in cancer screening participation: examining differences in perceived benefits and barriers.
    Smith SG; McGregor LM; Raine R; Wardle J; von Wagner C; Robb KA
    Psychooncology; 2016 Oct; 25(10):1168-1174. PubMed ID: 27309861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale.
    Davis M; Oaten M; Tapp C; Occhipinti S
    Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13661. PubMed ID: 35851704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis.
    Toes-Zoutendijk E; de Jonge L; van Iersel CA; Spaander MCW; van Vuuren AJ; van Kemenade F; Ramakers CR; Dekker E; Nagetaal ID; van Leerdam ME; Lansdorp-Vogelaar I
    Gut; 2023 Jul; 72(7):1319-1325. PubMed ID: 37076272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial.
    Regge D; Iussich G; Senore C; Correale L; Hassan C; Bert A; Montemezzi S; Segnan N
    Trials; 2014 Mar; 15():97. PubMed ID: 24678896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer screening with faecal occult blood testing: community intention, knowledge, beliefs and behaviour.
    Tong S; Hughes K; Oldenburg BB; Mar CD
    Asia Pac J Public Health; 2006; 18(1):16-23. PubMed ID: 16629434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing behavioral interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain.
    Stoffel S; Benito L; Milà N; Travier N; Binefa G; Vidal C; Espinosa J; Moreno V; Garcia M
    Prev Med; 2019 Feb; 119():58-62. PubMed ID: 30594532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams.
    Zheng YF; Saito T; Takahashi M; Ishibashi T; Kai I
    BMC Public Health; 2006 Nov; 6():272. PubMed ID: 17083746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gain versus loss-framed messaging and colorectal cancer screening among African Americans: A preliminary examination of perceived racism and culturally targeted dual messaging.
    Lucas T; Hayman LW; Blessman JE; Asabigi K; Novak JM
    Br J Health Psychol; 2016 May; 21(2):249-67. PubMed ID: 26333060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting patient adherence to publicly funded colorectal cancer screening programmes: a systematic review.
    Dressler J; Johnsen AT; Madsen LJ; Rasmussen M; Jorgensen LN
    Public Health; 2021 Jan; 190():67-74. PubMed ID: 33360029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
    Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
    Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Promotional Materials on Attitudes and Fear towards Colorectal Cancer Screening among Chinese Older Adults: An Experimental Study.
    Leung DYP; Chen JMT; Lou VWQ; Wong EML; Chan AWK; So WKW; Chan CWH
    Int J Environ Res Public Health; 2017 Jul; 14(7):. PubMed ID: 28703752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening.
    Gimeno García AZ; Quintero E; Nicolás Pérez D; Hernández M; JiménezSosa A
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1165-71. PubMed ID: 21989122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosocial consequences of invitation to colorectal cancer screening: a matched cohort study.
    Malmqvist J; Siersma V; Hestbech MS; Nicolaisdóttir DR; Bang CW; Brodersen J
    J Epidemiol Community Health; 2021 Sep; 75(9):867-873. PubMed ID: 33622803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study.
    Koo JH; Leong RW; Ching J; Yeoh KG; Wu DC; Murdani A; Cai Q; Chiu HM; Chong VH; Rerknimitr R; Goh KL; Hilmi I; Byeon JS; Niaz SK; Siddique A; Wu KC; Matsuda T; Makharia G; Sollano J; Lee SK; Sung JJ;
    Gastrointest Endosc; 2012 Jul; 76(1):126-35. PubMed ID: 22726471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facilitators and barriers to colorectal cancer screening using the immunochemical faecal occult blood test among an average-risk population in semi-rural Malaysia: A qualitative study.
    Ramanathan K; Schliemann D; Binti Ibrahim Tamin NS; Mohan D; Donnelly M; Su TT
    PLoS One; 2022; 17(12):e0279489. PubMed ID: 36580458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.